Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gan Mai Bai He Di Huang Tang (GMBHDHT) is a traditional Chinese medicine (TCM) herbal combination formula being investigated by Hong Kong Baptist University for the treatment of perimenopausal syndrome (PMS). The formula is specifically indicated for patients diagnosed with the Liver and Kidney Yin Deficiency syndrome pattern, which is characterized by symptoms such as hot flushes, night sweats, insomnia, and irritability. GMBHDHT is a hybrid decoction combining elements of Gan Mai Bai He Tang (a variation of the classical Gan Mai Da Zao Tang) and Di Huang Tang (typically based on Rehmannia glutinosa). In clinical trial settings, it is administered as water-soluble granules. The formula is part of a personalized medicine approach where TCM practitioners prescribe specific herbal combinations based on individual syndrome differentiation rather than a standardized fixed formula.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gan Mai Bai He Di Huang Tang.